86 related articles for article (PubMed ID: 15474466)
1. A novel auto-cleavage assay for studying mutational effects on the active site of severe acute respiratory syndrome coronavirus 3C-like protease.
Shan YF; Li SF; Xu GJ
Biochem Biophys Res Commun; 2004 Nov; 324(2):579-83. PubMed ID: 15474466
[TBL] [Abstract][Full Text] [Related]
2. Mutational and inhibitive analysis of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer-based assays.
Kuang WF; Chow LP; Wu MH; Hwang LH
Biochem Biophys Res Commun; 2005 Jun; 331(4):1554-9. PubMed ID: 15883050
[TBL] [Abstract][Full Text] [Related]
3. 3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism.
Huang C; Wei P; Fan K; Liu Y; Lai L
Biochemistry; 2004 Apr; 43(15):4568-74. PubMed ID: 15078103
[TBL] [Abstract][Full Text] [Related]
4. Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti-SARS drugs.
Lin CW; Tsai CH; Tsai FJ; Chen PJ; Lai CC; Wan L; Chiu HH; Lin KH
FEBS Lett; 2004 Sep; 574(1-3):131-7. PubMed ID: 15358553
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique.
Chen S; Chen LL; Luo HB; Sun T; Chen J; Ye F; Cai JH; Shen JK; Shen X; Jiang HL
Acta Pharmacol Sin; 2005 Jan; 26(1):99-106. PubMed ID: 15659121
[TBL] [Abstract][Full Text] [Related]
6. Identification of active-site amino acid residues in the Chiba virus 3C-like protease.
Someya Y; Takeda N; Miyamura T
J Virol; 2002 Jun; 76(12):5949-58. PubMed ID: 12021327
[TBL] [Abstract][Full Text] [Related]
7. Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors.
Shi J; Wei Z; Song J
J Biol Chem; 2004 Jun; 279(23):24765-73. PubMed ID: 15037623
[TBL] [Abstract][Full Text] [Related]
8. Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.
Ferreira JC; Fadl S; Villanueva AJ; Rabeh WM
Front Chem; 2021; 9():692168. PubMed ID: 34249864
[TBL] [Abstract][Full Text] [Related]
9. In silico analysis of ORF1ab in coronavirus HKU1 genome reveals a unique putative cleavage site of coronavirus HKU1 3C-like protease.
Woo PC; Huang Y; Lau SK; Tsoi HW; Yuen KY
Microbiol Immunol; 2005; 49(10):899-908. PubMed ID: 16237267
[TBL] [Abstract][Full Text] [Related]
10. Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode.
Chen S; Jonas F; Shen C; Hilgenfeld R
Protein Cell; 2010 Jan; 1(1):59-74. PubMed ID: 21203998
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus.
Sun H; Luo H; Yu C; Sun T; Chen J; Peng S; Qin J; Shen J; Yang Y; Xie Y; Chen K; Wang Y; Shen X; Jiang H
Protein Expr Purif; 2003 Dec; 32(2):302-8. PubMed ID: 14965777
[TBL] [Abstract][Full Text] [Related]
12. The substrate specificity of SARS coronavirus 3C-like proteinase.
Fan K; Ma L; Han X; Liang H; Wei P; Liu Y; Lai L
Biochem Biophys Res Commun; 2005 Apr; 329(3):934-40. PubMed ID: 15752746
[TBL] [Abstract][Full Text] [Related]
13. Residues on the dimer interface of SARS coronavirus 3C-like protease: dimer stability characterization and enzyme catalytic activity analysis.
Chen S; Zhang J; Hu T; Chen K; Jiang H; Shen X
J Biochem; 2008 Apr; 143(4):525-36. PubMed ID: 18182387
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase.
Fan K; Wei P; Feng Q; Chen S; Huang C; Ma L; Lai B; Pei J; Liu Y; Chen J; Lai L
J Biol Chem; 2004 Jan; 279(3):1637-42. PubMed ID: 14561748
[TBL] [Abstract][Full Text] [Related]
15. Long-range cooperative interactions modulate dimerization in SARS 3CLpro.
Barrila J; Bacha U; Freire E
Biochemistry; 2006 Dec; 45(50):14908-16. PubMed ID: 17154528
[TBL] [Abstract][Full Text] [Related]
16. Identification of the putative staphylococcal AgrB catalytic residues involving the proteolytic cleavage of AgrD to generate autoinducing peptide.
Qiu R; Pei W; Zhang L; Lin J; Ji G
J Biol Chem; 2005 Apr; 280(17):16695-704. PubMed ID: 15734745
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the active centre of coronavirus 3C-like proteases.
Hegyi A; Friebe A; Gorbalenya AE; Ziebuhr J
J Gen Virol; 2002 Mar; 83(Pt 3):581-593. PubMed ID: 11842253
[TBL] [Abstract][Full Text] [Related]
18. Identification of essential amino acid residues in the functional activity of poliovirus 2A protease.
Yu SF; Lloyd RE
Virology; 1991 Jun; 182(2):615-25. PubMed ID: 1850921
[TBL] [Abstract][Full Text] [Related]
19. The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase.
Wei P; Fan K; Chen H; Ma L; Huang C; Tan L; Xi D; Li C; Liu Y; Cao A; Lai L
Biochem Biophys Res Commun; 2006 Jan; 339(3):865-72. PubMed ID: 16329994
[TBL] [Abstract][Full Text] [Related]
20. The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain.
Shi J; Song J
FEBS J; 2006 Mar; 273(5):1035-45. PubMed ID: 16478476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
